Management of heart failure in the elderly

Current Cardiology Reports

Volumn 5, Issue 3, 2003, Pages 223-228

  Kerzner, Roger ^a   Rich, Michael W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; BUCINDOLOL; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CARVEDILOL; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FUROSEMIDE; HYDRALAZINE; LISINOPRIL; LOSARTAN; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PLACEBO; SEDATIVE AGENT; SPIRONOLACTONE; TORASEMIDE; VERAPAMIL;

AGED; ARTIFICIAL HEART PACEMAKER; AWARENESS; BEHAVIOR THERAPY; BLOOD ANALYSIS; CLINICAL TRIAL; COMORBIDITY; CORONARY ARTERY DISEASE; COUGHING; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIET THERAPY; DRUG DOSE REGIMEN; DRUG INHIBITION; DYING; ECHOCARDIOGRAPHY; ELDERLY CARE; EPIDEMIC; EVIDENCE BASED MEDICINE; HEART FAILURE; HUMAN; PATIENT CARE; RELAPSE; REVIEW; SIDE EFFECT; SOCIAL PSYCHOLOGY; TREATMENT OUTCOME; TREATMENT PLANNING; CONGESTIVE HEART FAILURE; DISEASE MANAGEMENT; HEART LEFT VENTRICLE FUNCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE; PROGNOSIS; UNITED STATES;

AGED; AGED, 80 AND OVER; DISEASE MANAGEMENT; HEART FAILURE, CONGESTIVE; HUMANS; PREVALENCE; PROGNOSIS; UNITED STATES; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 0038749452     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-003-0053-9     Document Type: Review

References (50)

1. American Heart Association. Biostatistical fact sheet: older Americans and cardiovascular diseases. Dallas: American Heart Association; 2002. www.americanheart.org.
2. Pulignano G, Del Sindaco D, Tavazzi L, et al.: Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry). Am Heart J 2002, 143:45-55.
3. Khand AU, Gemmel I, Rankin AC, Cleland JGF: Clinical events leading to the progression of heart failure: Insights from a national database of hospital discharges. Eur Heart J 2001, 22:153-164.
4. Havranek EP, Masoudi FA, Westfall KA, et al.: Spectrum of heart failure in older patients: results from the National Heart Failure Project. Am Heart J 2002, 143:412-417.
5. Rich MW: Management of heart failure in the elderly. Heart Fail Rev 2002, 7:89-97.
6. Zile MR, Brutsaert DL: New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 2002, 105:1387-1393.
7. Kitzman DW, Gardin JM, Gottdiener JS, et al.: Importance of heart failure with preserved systolic function in patients > 65 years of age. Am J Cardiol 2001, 87:413-419.
8. Staniforth AD, Kinnear WJM, Cowley AJ: Cognitive impairment in heart failure with Cheyne-Stokes respiration. Heart 2001, 85:18-22.
9. Zuccala G, Onder G, Pedone C, et al.: Cognitive dysfunction as a major determinant of disability in patients with heart failure: results from a multicenter survey. J Neurol Neurosurg Psychiatry 2001, 70:109-112.
10. Williams SA, Kasl SV, Heiat A, et al.: Depression and risk of heart failure among the elderly: a prospective community-based study. Psychosom Med 2002, 64:6-12.
11. Jiang W, Alexander J, Christopher E, et al.: Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001, 161:1849-1856.
12. Rozzini R, Sabatini T, Frisoni GB, Trabucchi M: Depression and major outcomes in older patients with heart failure. Arch Intern Med 2002, 162:362-363.
13. Ekman I, Fagerberg B, Lundman B: Health-related quality of life and sense of coherence among elderly patients with severe chronic heart failure in comparison with healthy controls. Heart Lung 2002, 31:94-101.
14. van Jaarsveld CHM, Sanderman R, Miedema I, et al.: Changes in health-related quality of life in older patients with acute myocardial infarction or congestive heart failure: a prospective study. J Am Geriatr Soc 2001, 49:1052-1058.
15. Feenstra J, Heerdink ER, Grobbee DE, Stricker BHC: Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam study. Arch Intern Med 2002, 162:265-270.
16. Maisel AS, Krishnaswamy P, Nowak RM, et al.: Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002, 347:161-167.
17. McCullough PA, Nowak RM, McCord J, et al.: B-type natriuretic peptide and clinical judgement in emergency diagnosis of heart failure: Analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 2002, 106:416-422.
18. Smith H, Pickering RM, Struthers A, et al.: Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study. Br Med J 2000, 320:906-908.
19. Tamura K, Takahashi N, Nakatani Y, et al.: Prognostic impact of plasma brain natriuretic peptide for cardiac events in elderly patients with congestive heart failure. Gerontology 2001, 47:46-51.
20. Redfield MM, Rodeheffer RJ, Jacobsen SJ, et al.: Plasma brain natriuretic peptide concentration: Impact of age and gender. J Am Coll Cardiol 2002, 40:976-982.
21. Thomas JT, Kelly RF, Thomas SJ, et al.: Utility of history, physical examination, electrocardiogram and chest radiograph for differentiating normal from decreased systolic function in patients with heart failure. Am J Med 2002, 112:437-445.
22. Heiat A, Gross CP, Krumholz HM: Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Md 2002, 162:1682-1688.
23. Valle R, Chinellato M, Milani L: Impact of guideline-based management on outcomes of very old persons with heart failure living in nursing homes. Arch Intern Med 2001, 161:2264-2265.
24. Chen Y, Wang Y, Radford MJ, Krumholz HM: Angiotension-converting enzyme inhibitor dosages in elderly patients with heart failure. Am Heart J 2001, 141:410-417.
25. Lapane KL, Hume AL, Barbour MM, Lipsitz LA: Does aspirin attenuate the effect of angiotensin-converting enzyme inhibitors on health outcomes of very old patients with heart failure? J Am Geriatr Soc 2002, 50:1198-1204.
26. Krumholz HM, Chen Y, Radford MJ: Aspirin and the treatment of heart failure in the elderly. Arch Intern Med 2001, 161:577-582.
27. Dickstein K, Kjekshus J, and the OPTIMAAL Steering Committee for the OPTIMAAL Study Group: Effects of losartan and captopril on mortality in high-risk patients after an acute myocardial infarction: the OPTIMAAL randomized trial. Lancet 2002, 360:752-760.
28. Pitt B, Poole-Wilson PA, Segal R, et al.: Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomized trial-the Losartan Heart Failure Survival Study ELITE II. Lancet 2000, 355:1582-1587.
29. Packer M, Coats AJS, Fowler MB, et al.: Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001, 344:1651-1658.
30. The Beta-Blocker Evaluation of Survival Trial Investigators: A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med 2001, 344:1659-1667.
31. Aranda JM, Krause-Stienrauf HJ, Greenberg BH, et al.: Comparison of the beta-blocker bucindolol in younger versus older patients with heart failure. Am J Card 2002, 89:1322-1326.
32. The Digitalis Investigation Group: The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997, 336:525-533.
33. Rich MW, McSherry F, Williford WO, Yusuf S, for the Digitalis Investigation Group: Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study. J Am Coll Cardiol 2001, 38:806-813.
34. Howard PA, Dunn MI: Aggressive diuresis for severe heart failure in the elderly. Chest 2001, 119:807-810.
35. Murray MD, Deer MM, Ferguson JA, et al.: Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure. Am J Med 111:513-520.
36. Colucci WS, Elkayam U, Horton DR et al.: Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. N Engl J Med 2000, 343:246-253.
37. Philbin EF, Rocco TA, Lindenmuth NW, et al.: Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am J Med 2000, 109:605-613.
38. Ahmed A, Roseman JM, Duxbury AS, et al.: Correlates and outcomes of preserved left ventricular systolic function among older adults hospitalized with heart failure. Am Heart J 2002, 144:365-372.
39. Hung MJ, Cherng WJ, Wang CH: Effect of verapamil in elderly patients with left ventricular diastolic dysfunction as a cause of congestive heart failure. Int J Clin Pract 2002, 56:57-62.
40. Warner JG, Metzger DC, Kitzman DW, et al.: Losartan improves exercise tolerance with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Cardiol 1999, 33:1567-1572.
41. Zile MR, Brutsaert DL: New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation 2002, 105:1503-1508.
42. Abraham WT, Fisher WG, Smith AL, et al.: Cardiac resynchronization in chronic heart failure. N Engl J Med 2002, 346:1845-1853.
43. Linde C, Lelercq C, Rex S, et al.: Long-term benefit of biventricular pacing in congestive heart failure: results from the Multisite Stimulation In Cardiomyopathy study. J Am Coll Cardiol 2002, 40:111-118.
44. Lamas GA, Lee KL, Sweeny MO, et al.: Ventricular pacing or dual-chamber pacing for sinus node dysfunction. N Engl J Med 2002 346:1854-1862.
45. McAlister FA, Lawson FME, Teo KK, Armstrong PW: A systematic review of randomized trials of disease management programs in congestive heart failure. Am J Med 2001, 110:378-384.
46. Stewart S, Horowitz J: Home-based intervention in congestive heart failure: long-term implications on readmission and survival. Circulation 2002, 105:2861-2866.
47. McDonald K, Ledwidge M, Cahill J, et al.: Heart failure management: multidisciplinary care has intrinsic benefit above the optimization of medical care. J Cardiac Fail 2002, 8:142-148.
48. Levy D, Kenchaiah S, Larson MG, et al.: Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002, 347:1397-1402.
49. Murray SA, Boyd K, Kendall M, et al.: Dying of lung cancer or cardiac failure: prospective qualitative interview study of patients and their careers in the community. Br Med J 2002, 325:929-932.
50. Levenson JW, McCarthy EP, Lynn J, et al.: The last six months of life for patients with congestive heart failure. J Am Geriatr Soc 2000, 48:S101-109.